510(k) Report

510(k) · Cleared

Cleared

Hemoglobin Capillary Collection System (HCCS), 1 Test, Hemoglobin Capillary Collection System (HCCS), 5 Tests, Hemoglobi

K090737510(k) TraditionalCleared Jun 3, 200975-day reviewClass II21 CFR 862.1675

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories, Inc. · JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

Cleared on Jun 3, 2009 as substantially equivalent to K070452 (Bio-Rad Laboratories, Inc., 2007) and 1 other predicate after a 75-day review. Its family tree reaches back 3 generations to 1993.

Decided
Jun 3, 2009
Review
75 days
Class
Class II
Product code
JKA
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K926469 (1993). 4 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK926469 Variant (TM) Hemoglobin a 1C ProgramBio-Rad · 1993
  2. 2 generations backK984268 Variant II Hemoglobin A1C ProgramBio-Rad · 1998 · Recalled
  3. 1 generation backK031043 D-10 Hemoglobin A1CBio-Rad Laboratories, Inc. · 2003 · Recalled
  4. This deviceK090737 Hemoglobin Capillary Collection System (HCCS), 1 Test, Hemoglobin…Bio-Rad Laboratories, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K926469Variant (TM) Hemoglobin a 1C ProgramBio-Rad1993—
−2K984268Variant II Hemoglobin A1C ProgramBio-Rad19982
−1K031043D-10 Hemoglobin A1CBio-Rad Laboratories, Inc.20036
0 (this device)K090737Hemoglobin Capillary Collection System (HCCS), 1 Test, Hemoglobin Capillary…Bio-Rad Laboratories, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K090737, 1993–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JKA device

  1. #1 K200027 Blood Collection Needle with/without Holder…score 15.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070452Variant II Hemoglobin A1C Program with Models 270-2101NU
Summary page 1
…n Name: Blood specimen collection device, JKA Assay, Glycosylated hemoglobin, LCP Predicate Devices: VARIANTTM II Hemoglobin Alc Program, Bio-Rad Laboratories, Inc., K070452 - Wash/Diluent Solution D-10TM Hemoglobin Aic Program, Bio-Rad Laboratories, Inc., K03 1043 - Wash/Diluent Solution Intended Us…
Bio-Rad Laboratories, Inc.20071
*K031043D-10 Hemoglobin A1C
Summary page 1
…te Devices: VARIANTTM II Hemoglobin Alc Program, Bio-Rad Laboratories, Inc., K070452 - Wash/Diluent Solution D-10TM Hemoglobin Aic Program, Bio-Rad Laboratories, Inc., K03 1043 - Wash/Diluent Solution Intended Use: The Hemoglobin Capillary Collection System (HCCS) is intended for the collection of human…
Bio-Rad Laboratories, Inc.20036

Also cleared against K070452: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 5.7 years on median.
  • 3 of the 4 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K070452.

How does its category compare?

All JKA devices

JKA Tubes, Vials, Systems, Serum Separators, Blood Collection: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · JKA

7in 2025

2007: 42008: 22009: 22010: 42012: 12013: 32014: 12015: 12016: 42017: 22018: 12019: 62020: 62021: 42022: 92023: 172024: 62025: 72026 (partial year): 8
2007high 17 (2023) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JKA

115in 2025

2007: 281 days median2010: 28 days median2013: 244 days median2016: 116 days median2019: 181 days median2020: 181 days median2021: 217 days median2022: 164 days median2023: 189 days median2024: 240 days median2025: 115 days median2026 (partial year): 250 days median
2007high 281 (2007) · low 28 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JKA

13in 2025

2007: 32008: 32009: 32010: 42011: 142012: 22013: 12014: 12015: 62016: 12017: 22018: 22019: 92021: 32022: 22023: 22025: 132026 (partial year): 1
2007high 14 (2011) · low 0 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JKA

6,089in 2025

2007: 732008: 782009: 422010: 372011: 672012: 542013: 332014: 682015: 412016: 652017: 2,0392018: 9,7312019: 6,4692020: 3,7742021: 3,6102022: 3,3752023: 4,4002024: 4,6092025: 6,089
2007high 9,731 (2018) · low 33 (2013)2025

MAUDE reports naming product code JKA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074281373
20082—378
20092—342
2010428437
20110—1467
20121—254
20133244133
20141—168
20151—641
20164116165
20172—22,039
20181—29,731
2019618196,469
2020618103,774
2021421733,610
2022916423,375
20231718924,400
2024624004,609
20257115136,089
202682501—

What is it indicated for?

The Hemoglobin Capillary Collection System (HCCS) is intended for the collection of human whole blood for the percent determination of hemoglobin A1c using Bio-Rad HPLC methods.

For in vitro diagnostic use.

The measurement of percent hemoglobin A1c is effective in monitoring long-term glucose control in individuals with diabetes mellitus.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090737: Hemoglobin Capillary Collection System (HCCS), 1 Test, Hemoglobin Capillary Collection System (HCCS), 5 Tests, Hemoglobi.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090737

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026